General Info
NG Bio is a therapeutic ventures that can change outcomes for patients with autoimmune and chronic inflammatory diseases.
Location: London
Country:
Industries:
Investment Regions: EU
Investment Stages: late-stage, pre-seed, seed, series-a
Website: https://ngbio.co.uk/
vc
EU
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-active
AI Reasoning: NG Bio’s portfolio page lists investments including LightOx, Abselion, Cellesce (acquired), Bastion Therapeutics, and Mesenbio. The site footer shows © 2024; there are no press releases or portfolio additions dated in 2025. The latest public evidence of an investment or portfolio activity is from 2024 (e.g., Cellesce acquisition noted prior to 2025). That indicates the last known investment occurred more than 12 months ago, so classify as not-active.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of NG Bio
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI